Cas:6133-64-8 pyrimido[4,5-d]triazine manufacturer & supplier

Chemical Name:pyrimido[4,5-d]triazine

CAS.NO:6133-64-8

Synonyms:pyrimido[4,5-d]-1,2,3-triazine;1,2,3,6,8-Pentaazanaphthalene;Pyrimido[4,5-d]-1,2,3-triazine (9CI)

Molecular Formula:C₅H₃N₅

Molecular Weight:133.11100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:64.45000

Exact Mass:133.03900

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like pyrimido[4,5-d]-1,2,3-triazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrimido[4,5-d]-1,2,3-triazine (9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,pyrimido[4,5-d]-1,2,3-triazine Use and application,pyrimido[4,5-d]-1,2,3-triazine technical grade,usp/ep/jp grade.

Related News: The three products for which it received the PLI approvals are betamethasone with a production capacity of 12 MT at an investment of Rs 31.43 crore, dexamethasone of 10 MT with an investment of Rs. 26.19 crore and prednisolone of 15 MT at Rs 39. 29 crore. This takes the total investment to Rs 96.91 core. 4-fluorobenzylmagnesium chloride 0.25m& manufacturers Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. Hexaflumuron suppliers Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. 4-Hydroxy-TEMPO vendor & factory In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April.,Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine.